tetano
Editor, Senior Moderator
Clin Kidney J
. 2021 Apr 15;14(9):2000-2011.
doi: 10.1093/ckj/sfab073. eCollection 2021 Sep.
Kidney involvement in multisystem inflammatory syndrome in children: a pediatric nephrologist's perspective
Sidharth Kumar Sethi[SUP] 1 [/SUP], Abhyuday Rana[SUP] 2 [/SUP], Harsha Adnani[SUP] 3 [/SUP], Mignon McCulloch[SUP] 4 [/SUP], Khalid Alhasan[SUP] 5 [/SUP], Azmeri Sultana[SUP] 6 [/SUP], Rama Safadi[SUP] 7 [/SUP], Nirav Agrawal[SUP] 3 [/SUP], Rupesh Raina[SUP] 7 8 [/SUP]
Affiliations
Abstract
The initial report of the multisystem inflammatory syndrome in children (MIS-C) was from the UK in April 2020; since then, cases have been reported worldwide. Renal involvement has been seen commonly, ranging from 10% to 46%. Kidney involvement following severe acute respiratory syndrome coronavirus 2 infection in children with MIS-C is more common than initially thought and is associated with higher morbidity and mortality. There are several reports of a direct viral tropism of coronavirus disease 2019 and MIS-C-associated renal damage. This study's objective was to systematically review the current understanding of kidney involvement in children suffering from MIS-C. Based on our systemic literature search, 19 studies have either partially or fully discussed kidney involvement in MIS-C patients. Furthermore, we discuss the multifactorial pathogenesis contributing to acute kidney injury (AKI) development in MIS-C. The current review gives a pediatric nephrologist's perspective of the renal involvement in MIS-C, the incidence of AKI, the pathophysiology of AKI in MIS-C and the proposed therapeutic regimens available, including the need for kidney replacement therapy for a child with AKI associated with MIS-C. As the disease is rapidly evolving, more detailed clinical prospective studies are required to understand MIS-C and its role in AKI better.
Keywords: COVID-19; MIS-C; acute kidney injury; nephrology.
. 2021 Apr 15;14(9):2000-2011.
doi: 10.1093/ckj/sfab073. eCollection 2021 Sep.
Kidney involvement in multisystem inflammatory syndrome in children: a pediatric nephrologist's perspective
Sidharth Kumar Sethi[SUP] 1 [/SUP], Abhyuday Rana[SUP] 2 [/SUP], Harsha Adnani[SUP] 3 [/SUP], Mignon McCulloch[SUP] 4 [/SUP], Khalid Alhasan[SUP] 5 [/SUP], Azmeri Sultana[SUP] 6 [/SUP], Rama Safadi[SUP] 7 [/SUP], Nirav Agrawal[SUP] 3 [/SUP], Rupesh Raina[SUP] 7 8 [/SUP]
Affiliations
- PMID: 34471522
- PMCID: PMC8083308
- DOI: 10.1093/ckj/sfab073
Abstract
The initial report of the multisystem inflammatory syndrome in children (MIS-C) was from the UK in April 2020; since then, cases have been reported worldwide. Renal involvement has been seen commonly, ranging from 10% to 46%. Kidney involvement following severe acute respiratory syndrome coronavirus 2 infection in children with MIS-C is more common than initially thought and is associated with higher morbidity and mortality. There are several reports of a direct viral tropism of coronavirus disease 2019 and MIS-C-associated renal damage. This study's objective was to systematically review the current understanding of kidney involvement in children suffering from MIS-C. Based on our systemic literature search, 19 studies have either partially or fully discussed kidney involvement in MIS-C patients. Furthermore, we discuss the multifactorial pathogenesis contributing to acute kidney injury (AKI) development in MIS-C. The current review gives a pediatric nephrologist's perspective of the renal involvement in MIS-C, the incidence of AKI, the pathophysiology of AKI in MIS-C and the proposed therapeutic regimens available, including the need for kidney replacement therapy for a child with AKI associated with MIS-C. As the disease is rapidly evolving, more detailed clinical prospective studies are required to understand MIS-C and its role in AKI better.
Keywords: COVID-19; MIS-C; acute kidney injury; nephrology.